Choose a supplement that provides at least 1,000 mg of combined EPA and DHA
Food and Drug Administration (FDA) approved Eli Lilly and Companys Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM)
Adeyinka, A., & Kondamudi, N.P
These medications are FDA-approved specifically for type 2 diabetes management or chronic weight loss, requiring prescriptions after medical evaluation and administered via weekly or daily injections
Insurers like United Healthcare may cover semaglutide treatments upon prior authorization for individuals with a BMI exceeding 30, or 27 with correlated conditions
It is important to note that semaglutide (Wegovy) is recommended by NICE for use within specialist weight management services and is subject to specific eligibility and time-limited prescribing criteria (NICE TA875: Semaglutide for managing overweight and obesity)